Pharmacology of argatroban

Author： Jeske W.   Walenga J.M.   Lewis B.E.   Fareed J.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.5, 1999-05, pp. : 625-654

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Argatroban

By McKeage K.   Plosker G.L.  

Drugs, Vol. 61, Iss. 4, 2001-01 ,pp. : 515-522

Adis International

Access to resources Recommend Favorite

Argatroban: A Viewpoint by Theodore E. Warkentin

By Warkentin T.E.  

Drugs, Vol. 61, Iss. 4, 2001-01 ,pp. : 523-524

Adis International

Access to resources Recommend Favorite

Argatroban use in heparin-induced thrombocytopenia

By Boggio Lisa N   Oza Veeral M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 11, 2008-08 ,pp. : 1963-1967

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome

By Cruz-González Ignacio   López-Jiménez Rosana   Perez-Rivera Angel   Yan Bryan P  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1483-1493

Informa Healthcare

Access to resources Recommend Favorite

Argatroban: Coagulation disorders in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1059, 2005-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite